TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Clinical trial NCT06726577 · RECRUITING
Trial details
- NCT number
- NCT06726577
- Sponsor
- Talengen Institute of Life Sciences, Shenzhen, P.R. China.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-10
- Primary completion
- 2027-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.